Pharmaceuticals R&D is on the rail now… Hanmi, LG invest 20percents

Domestic pharmaceutical companies’ commitment to R&D is on the rail now.

According to the 2014 first half R&D status analysis by dailypharm, the companies put about 449.6 billion won which is 6.5 percent of its sales into R & D. It is 0.3% increase, in other words, 59.4 billion won increase. There are 23 companies which decrease R & D-sales ratio, and among them, only 7 companies decrease more...